Evidence over narrative
Hypotheses are tested under explicit data, leakage, reproducibility and out-of-sample controls before they can support an investment decision.
We build, challenge and govern systematic investment research before proprietary capital is placed at risk.
Markets are uncertain by construction. Our response is not to make forecasts sound certain, but to build research systems that make assumptions visible, weak ideas easier to reject and investment decisions easier to audit.
Hypotheses are tested under explicit data, leakage, reproducibility and out-of-sample controls before they can support an investment decision.
Signals matter only after costs, sizing, interactions, concentration, liquidity and implementation constraints are considered.
Risk is a design constraint across research, allocation and monitoring—not a statistic appended after performance.
The research process is deliberately staged. Progression is controlled, negative evidence is preserved, and an attractive backtest is never treated as sufficient evidence by itself.
Identify a market behaviour, constraint or anomaly without assuming it is tradable.
State the economic or behavioural premise before tuning implementation.
Register assumptions, datasets, costs, variants and evaluation methodology.
Attack leakage, fragility, sensitivity and competing explanations.
Require evidence beyond the sample in which the idea was discovered.
Promote only research that satisfies the applicable governance gate.
Capital is considered only after research admission and portfolio-level constraints.
Markets change.
Models can fail.
Evidence must survive both.
Institutional discipline depends on traceability. Failed hypotheses, search iterations and control failures are part of the evidence—not material to be hidden when the narrative changes.
Illustrative interface only · no live strategy data shown
Material experiments must be recoverable and independently rerunnable.
Validation boundaries are treated as governance controls, not optional diagnostics.
Rejected work remains part of the permanent research record.
Capital preservation begins before a position is opened. Research validity, implementation quality, portfolio interaction and operational control all contribute to the risk of an investment system.
Parameter sensitivity, leakage, unstable assumptions and weak generalisation are challenged before capital allocation.
Position sizing, concentration, liquidity and regime dependence are treated at portfolio level.
Costs, slippage, timing and operational mechanics must survive realistic execution assumptions.
Research, approval, deployment and monitoring are separated through explicit gates and preserved records.
Sarvasvam is being built as a research-led investment organisation where process, evidence and governance compound before scale does.
Institutional enquiries